Bonum Certa Men Certa

Orrin Hatch, Sponsored the Most by the Pharmaceutical Industry, Tries to Make Its Patents Immune From Scrutiny (PTAB)

American (US) pharmaceutical patents on Canadian soil are meanwhile at risk as a result of Trump's trade war that invites retaliation

Orrin Hatch's funding
Source: OpenSecrets



Summary: Orrin Hatch is the latest example of laws being up for sale, i.e. companies can 'buy' politicians to act as their 'couriers' and pass laws for them, including laws pertaining to patents

THE SCOTUS issued some important rulings such as Alice and Mayo, which meant that patents granted by the USPTO may, in retrospect, be invalid. The Saint Regis Mohawk Tribe is attempting to shield Allergan from the Patent Trial and Appeal Board (PTAB), the only tribunal that can render Allergan's patents invalid unless Allergan sues. All sorts of pharmaceutical patents are under a similar threat from PTAB and Mr. Kyle Bass made headlines some years ago when he used PTAB as a 'weapon'. His 'threat' was ending a monopoly.

The subject of immunity from PTAB is now at the Federal Circuit and we need to question the motivation of politicians who take Allergan's side, even based on their sources of funding alone.

"Watchtroll likes to heckle politicians who receive money from technology firms, but what about pharmaceutical firms?"To be clear, in the area of technology pretty much all the companies -- both large and small -- support PTAB, except a few like IBM, which nowadays relies on patent shakedowns rather than sales (we have been saying this for years [1, 2, 3, 4, 5]). Watchtroll likes to heckle politicians who receive money from technology firms, but what about pharmaceutical firms? Or law firms (third in Orrin Hatch's list)? We'll come to that in a moment. In case it's not obvious, in the pharmaceutical sector the notion of patent trolls is rare and practically ineffective because the number of producing firms is relatively small. It just doesn't scale. So PTAB is of virtually no use for large pharmaceutical firms; it mostly puts them under the 'threat' from generics (we use scare quotes because this the real threat is a threat to people's lives due to the price of certain medicine -- monopolised medicine).

The USPTO's SAS decision "isn't good for the efficiency of the PTAB inter-partes review (IPR)," Florian Müller wrote a short time ago (as noted in yesterday's post of ours), unlike Oil States. Here are some passages:

Samsung challenged multiple claims of two of Huawei's patents-in-suit. The USPTO decided to institute reexamination with respect to some of them, but it had to issue a supplemental order in the wake of SAS and look--nolens volens--at all challenged claims, though it encouraged Samsung to drop its challenge to the ones with respect to which the USPTO was originally unconvinced.

Huawei had actually focused, for the purposes of infringement litigation, on the claims the USPTO viewed more favorably, but the SAS decision changed everything.

As I wrote in my commentary on SAS, this isn't good for the efficiency of the PTAB inter-partes review (IPR) process, but the conservative Supreme Court majority was right that the way the law was worded didn't leave room for any other decision, short of legislating from the bench, which most justices declined to engage in.


There have long been attempts to slow down if not shut down PTAB. These attempts came mostly from pharmaceutical giants and the patent microcosm. Days ago we named involvement by Hatch. This anti-PTAB move is now being covered by Dennis Crouch and Watchtroll, who spent his Sunday badmouthing the cause of generics. To quote Crouch's take (something we already covered twice in recent days, saying we'd check Hatch's contributions to know if indeed he's in the pockets of big pharmaceutical companies):

The basics of the amendment is that the results of an IPR/PRG proceeding cannot serve as its Paragraph IV certification that the patent is invalid. A parallel provision is designed for biologics under the BCPIA.


Suddenly everyone starts talking about this; it's seen as the latest anti-PTAB angle. See Bryan Helwig's "Life Sciences Court Report" (published hours ago) and this Twitter exchange involving Senior Lecturer Luke McDonagh (who comments a lot on UPC), patent attorney Alexander Esslinger (Team UPC), and Jonathan Kimmelman (Bioethicist/Meta-scientist). "Canada is discussing to make pharmaceutical patents unenforceable in Canada aiming at US pharmaceutical industry as retaliatory action against Donald Trump‘s tariffs IP [sic] trade war," Esslinger wrote in relation to this article from CBC (Canada). To quote:

And so Attaran is suggesting that Canada take aim at U.S. drug patents.

The U.S. holds more pharmaceutical patents and other intellectual property licences than any other country. But that strength could become a vulnerability if Canada took action to suspend American patents on Canadian soil. Canadian companies would then be able to produce those drugs.

"You hit us on tariffs, we hit you on patents," he said.


Hours ago Keith Speights published "Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming" -- an article in which he says:

How scary is the impending patent cliff? It's not as bad as you might think.

The worst brunt won't be felt until 2023. Total sales at risk due to patent expiration will actually be much lower than in recent years in 2020, 2021, and even 2024.

Also, just because sales are at risk doesn't mean that those sales will completely be lost. EvaluatePharma projects that roughly $139 billion in sales will be lost between 2018 and 2024 for drugs that go off-patent. That's a big number, but it's also much lower than the $250-plus billion in sales that are at risk during the period.

Humira, for example, is still expected to be the world's No. 1 drug in 2024, with sales of more than $15.2 billion. EvaluatePharma thinks that Revlimid will slip a spot from No. 2 to No. 3, but will still grow robustly and generate revenue of close to $8.2 billion annually seven years from now.

Johnson & Johnson has demonstrated the ability to hold on to most of the revenue for Remicade despite losing patent exclusivity. However, J&J's tactics have been controversial and spurred Pfizer to sue for alleged violation of antitrust laws.

EvaluatePharma's report noted that many analysts aren't too concerned about Novo Nordisk's patent cliff. The firm stated that sales expectations for Novo's drugs that have or will lose patent protection continue to remain relatively high, probably because of "the historical sales erosion seen for injected diabetes therapy."


The bottom line is, the value of many companies associated with medicine depends greatly on patents. We do not generally oppose such patents, but we certainly oppose making such patents immune from PTAB. This effort from Hatch is currently being exploited by the anti-PTAB lobby and Hatch seems to be motivated by bribes rather than concerns for public health. Millions of dollars for Hatch to help guard multi-billion monopolies certainly make "business sense". ⬆

Recent Techrights' Posts

Harassment by Proxy in America - Part II - Decades of Misusing the Human Rights Tribunal of Ontario (HRTO)
We had seen this for quite some time
An Alluring Fantasy of Charlatans and Frauds
Last week we said that Huang should probably be arrested, not sacked
 
Links 22/11/2026: "The Bubble is Bursting" and "The Anthropic Bubble"
Links for the day
Andy Explains the 'Ritual' of Buy Nothing Day
old article about Buy Nothing Day
A List of Nadella's Accomplishments at Microsoft
Two weeks ago (exactly 2 weeks) everyone believed that Jensen was an excellent CEO too
Richard Stallman Gives a Talk in Guayaquil Tomorrow
Richard Stallman (RMS) is giving many talks in Ecuador, then he'll give several talks in Mexico as well
A Week After Microsoft Outages Windows is Measured at Only ~60% in North American Desktops/Laptops
Microsoft gives 2 more weeks for 60,000 of its own workers to announce they're leaving
Techrights Was Never a Political Site, It Deals With Mostly Technical Topics
There are people who try to weaponise politics to accomplish bad things inside or against the community
Techrights '30 Years Ago'
Don't mock people for still offering HTTP (not HTTPS-only) as an option
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Saturday, November 21, 2026
IRC logs for Saturday, November 21, 2026
IBM Hiding Layoffs by Telling Staff to Leave
IBM isn't a serious employer anymore. It also hides layoffs by twisting them as "resignations".
Kyrgyzstan: GNU/Linux Rises Above 5%
statCounter sees GNU/Linux at about 6%
Intrigue and Interest in GNU/Linux is Growing
Those of us who grew up in the previous millennium are accustomed to GNU/Linux being "that geek platform" that sites ignore because "only 1%" and whatnot
Gemini Links 21/11/2026: Blue Wave, Wes Huff, Jujutsu, and Tape Cassette Storage
Links for the day
To Trump's Sponsors, Microsoft and IBM, the Trump Mandate to Stop Sponsoring Visa Holders Was Actually a Blessing (More "Silent Layoffs")
"This is an easy excuse"
Uganda: GNU/Linux Measured at About 6%
Clownflare and statCounter measures aren't far apart, the metrics are
Links 21/11/2026: "Google’s Embrace of Hey Hi (AI) Is Backfiring Spectacularly" and Proton Turns to Slop
Links for the day
Links 21/11/2026: Sites "Overwhelmed by Slop Bots" and "Former SEC Chairman Gary Gensler Says Slop Is "Already a Bubble," Set to Pop and Cause Economic Catastrophe"
Links for the day
Harassment by Proxy in America - Part I - Targeting Women in Other Continents
There's no masculinity more toxic than this
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Friday, November 20, 2026
IRC logs for Friday, November 20, 2026
Belatedly, the Real Nvidia Scandal (Corruption, Fraud) Comes Under US SEC Investigation
It had to happen soon or later
Gemini Links 20/11/2026: Electronic Rejection, Spectrum (Formerly Charter) Blocks Safe Websites, and Surveillance Jungle/Eavesdropping 1998
Links for the day
Links 20/11/2026: Microsoft to Pay in Shares Instead of Money and Over 10% at Intel Alleged at be Laid Off Again
Links for the day
IBM Will Continue to Sell Away Its Assets to Pay Salaries While Reducing Salaries (Fewer Workers, More Contractors, Offshoring)
The incredible thing is that the people who shrink IBM and lie to the media give themselves pay increases and bonuses
NVIDIA Corp Lost Almost Half Its 'Value' in a Matter of Weeks
the company that 'architected' or orchestrated this circular financing bubble is in peril
KDE is Good for Everybody
If Plasma isn't for "beginners", then why does does Valve made it the sole default in SteamOS/Steam Deck and why is it still around after 30+ years without any major controversy?
US Office of Government Ethics: NVIDIA Insider Trading by the Dictator of the US, Stock Soon 50% Below Its Value in October
It's just a rigged market, taxpayers are forced to pay for it (to bail out 'shy' billionaires)
Microsoft Morale Low, Drives Workers Crazy
Only a total moron with no grasp of technology would believe the catch-all excuse
No, IBM Didn't Lay Off Just "Hundreds" in 2026
These companies are rapidly shrinking. They just know how to hide what's really going on.
Slopapers: The Issue of Slop 'Wallpapers' Flooding the Repository in KDE and More
it's just an excuse that calls fusion (without attribution or any mention of a licence) "training" or "hey hi" or "fair use" or "superintelligence"
Links 20/11/2026: "Anthropic IPO [Shows] the AI Bubble Finally Popping" and New Problems With Slop Copyright Infringement
Links for the day
Richard Stallman, Founder of the GNU Project and a Co-founder of the FSF, Still Working With the FSF to Abolish Microsoft's Restricted Boot
Jack M. Germain has just published a lengthy article about GNU Boot
GNU/Linux Has Gained a Lot in Western Europe
Eastern Europe is another matter
IBM "Efficiency" is Working One's Way to the Bottom of the Remuneration Scale While Hiding the Stealth Layoffs
People still leaving
Forbes Already Stopped Being a News Site. Now It's a Spam and Propaganda Platform for "Paying Partners" (Companies).
news from Forbes became very scarce
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, November 19, 2026
IRC logs for Thursday, November 19, 2026
It's All About Restricted Boot and Microsoft
Garrett is working with Microsoft staff towards Microsoft agenda
Intercontinental Brigading - Part XXXXXVII - UK Isn't Part of the US or Russia
We have plenty to cover in the coming years
Update on Pocock v. Software in the Public Interest, Inc. (26-1766)
Case reassigned
Calling Frauds "Frauds" is Not Illegal
We are still getting the same vibe; Americans do not understand free speech, even if their country has a First Amendment
Everything is "AI" Now
"More Open Than Open [...] I am constantly amazed at the flexibility of this single word.”
Microsoft Web Sites Paint Mass Layoffs as Opportunities for Those Impacted, Mass Layoffs Alleged to Follow in January (to 'Kill Off' Survivors)
Keeping Up Appearances
Microsoft Outages Accelerate Migrations to Free Software
More than one major outage lately
Richard Stallman's Talks Next Month (Tech de Ciudad de México)
Right now is a very good time to promote Software Freedom because of recent world events